FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
40 | BEYOND THE USUAL CAT: TRICHOPHYTON BENHAMIAE KERION CELSI IN A CHILD WITH CHINCHILLA-ASSOCIATED HOUSEHOLD OUTBREAK T. Galeotti1, D. Tesauri1, P. Caposciutti1, L. Bianchi1, S. Crotti2, D. Cruciani2, K. Hansel1, L. Stingeni1 | 1Dermatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; 2Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche "Togo Rosati", Perugia, Italy
112PDF: 125 -
21 | Melanoma in situ: long-term outcomes and follow-up strategies based on risk stratification Beatrice De Checchi1, Paolo del Fiore2, Irene Russo2, Chiara Trevisiol2, Marco Domenico Mazza2, Saveria Tropea2, Francesco Russano2, Mauro Alaibac3, Carlomaria Gianesini4, Giovanni Madeo4, Simone Mocellin2|4 | 1Department of Medicine, University of Padua, Padua; 2Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; 3Department of Dermatology, University of Padua; 4Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
473 -
32 | Tebentafusp in metastatic uveal melanoma: 3 years of real world data and insights from liquid biopsy Luisa Piccin1, Maria Chiara Scaini2, Valentina Salizzato1, Cristina Catoni2, Elisabetta Di Liso1, Alice Menichetti1, Chiara Cacco1|4, Chiara Gottardi1|4, Francesca Di Sarra3, Marina Coppola3, Valentina Guarneri1|4, Jacopo Pigozzo1 | 1Medical Oncology 2 - Veneto Institute of Oncology IOV-IRCCS; 2Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS; 3Pharmacy Unit - Veneto Institute of Oncology IOV-IRCCS; 4Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy.
388 -
67 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, USA; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, Canada; 5Chang Gung University College of Medicine, Taoyuan, Taiwan; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany; 8Department of Dermatology and Population Health Sciences, King’s College London, UK; 9Ada West Dermatology, St Luke’s Children’s Hospital Idaho, USA; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney, Australia; 11Eli Lilly and Company, Indianapolis, Indiana, USA; 12Almirall R&D, S.A., Barcelona, Spain; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
129PDF: 65 -
12 | Integrated molecular and immunophenotypic profiling of uveal melanoma: prognostic insights and biological perspectives Francesco Fortarezza1, Giovanni Zarrilli2, Giada Munari1, Valentina Angerilli3, Mariangela Balistreri1, Luisa Piccin4, Valentina Salizzato4, Jacopo Pigozzo4, Giulia Midena5, Raffaele Parrozzani6, Valentina Guarneri4|7, Edoardo Midena5|6, Marta Sbaraglia1|8, Matteo Fassan8|9, Angelo Paolo Dei Tos1|8 | 1Surgical Pathology and Cytopathology Unit, Department of Integrated Diagnostics. Azienda Ospedale-Università Padova, Padua; 2Surgical Pathology Unit, Azienda Ulss 3 Serenissima, Ospedale dell'Angelo, Venezia; 3Department of Surgical Pathology, Azienda ULSS2 Marca Trevigiana, Treviso; 4Medical Oncology 2, Veneto Institute of Oncology, IOV-IRCCS, Padua; 5IRCCS-Fondazione Bietti, Rome; 6Department of Ophthalmology, University of Padova, Padova; 7Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua; 8Department of Medicine, University of Padua School of Medicine, Padua; 9Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
417 -
05 | Revisiting cancer risk associated with the MITF p.e318k variant beyond melanoma Debora Tonello1, Beatrice Zennaro1, Stefania Pellegrini1, Monica Quaggio2, Luisa Piccin3, Alessio Fabozzi4, Luigi Dall’Olmo2|5, Saveria Tropea5, Maria Chiara Scaini1, Chiara Menin1 | 1Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova; 2Department of Surgery, Oncology and Gastroenterology, Section of Immunology and Oncology, AIDS Reference Center, University of Padova, Padova; 3Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova; 4Oncology Unit 3, Veneto Institute of Oncology - IOV-IRCCS, Padua; 5Soft-Tissue, Peritoneum, and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
603 -
36 | MORBIHAN DISEASE IN A MAURITIAN PATIENT: A CASE REPORT AND REVIEW OF THE ASIAN LITERATURE G. Hoxhallari1|4, R. Bortone2, A. R. Meduri2, B. Tirone2, F. Drago3, C. Foti2, D. Bonamonte2, M. Bellino2, G. Ciccarese1 | 1Unit of Dermatology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy; 2Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari “Aldo Moro”, Bari, Italy; 3Casa di Cura Villa Montallegro, Genova, Italy; 4Department of Dermatology and Venereology, Mother Teresa University Hospital Center, Tirana, Albania
103PDF: 39 -
-
01 | THE SKIN: A COGNITIVE AND AFFECTIVE STORY G. Caresana | Dermatologic Surgery, Casa di Cura Piacenza, Italy
106PDF: 47 -
A rare case of keloid combined with bullous pemphigoid
1161PDF: 288HTML: 9 -
59 | EXPLORATORY THERAPEUTIC APPROACH IN DERCUM’S DISEASE: IMMUNOMODULATORS AND GLP-1 RECEPTOR AGONISTS A. Magnatta1, M. Caproni2 | 1Department of Health Sciences, Section of Dermatology, University of Florence, Italy; 2Department of Health Sciences, Rare Disease Dermatological Unit, Section of Dermatology, University of Florence, P. Palagi Hospital, Florence, Italy
114PDF: 31 -
04 | Association of a novel TERT polymorphism with poorer survival in male patients with melanoma Fortunato Cassalia1, Maria Santa Rocca2, Andrea Di Nisio3, Paolo del Fiore*4, Clara Benna5|7, Ilaria Cosci6, Simone Mocellin4|5, Alberto Ferlin*2|6 | 1Department of Dermatology, University of Padua, Padua; 2Unit of Andrology and Reproductive Medicine, University Hospital of Padua, Padua; 3Department of Wellbeing, Nutrition and Sport, Pegaso Telematic University, Naples; 4Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; 5Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua; 6Department of Medicine, University of Padua, Padua; 7Unit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy.
446
